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Novel nonadride, heptadride and maleic acid
metabolites from the byssochlamic acid producer
Byssochlamys fulva IMI 40021 – an insight into
the biosynthesis of maleidrides†
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Nicholas P. Mulholland,c Jason L. Vincent,c Christine L. Willis,a Russell J. Cox*ad
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The filamentous fungus Byssochlamys fulva strain IMI 40021 produces
(+)-byssochlamic acid 1, its novel dihydroanalogue 2 and four related
secondary metabolites. Agnestadrides A, 17 and B, 18 constitute a novel
class of seven-membered ring, maleic anhydride-containing (hence
termed heptadride) natural products. The putative maleic anhydride
precursor 5 for both nonadride and heptadride biosynthesis was iso-
lated as a fermentation product for the first time and its structure
confirmed by synthesis. Acid 5 undergoes facile decarboxylation to
anhydride 6. The generic term maleidrides is proposed to encompass
biosynthetically-related compounds containing maleic anhydride
moieties fused to an alicyclic ring, varying in size and substituents.
The collective name ‘‘nonadrides’’ was introduced by Barton and
Sutherland for fungal metabolites containing a nine-membered
ring fused to one or two maleic anhydride moieties in 1965.1 The
first of these, glaucanic acid 3 and glauconic acid 4 were isolated
from Penicillium glaucum,2 by Wijkman and reported in 1931. Soon
afterwards the pseudo-symmetrical analogue, byssochlamic acid 1
was isolated from the common food contaminant Byssochlamys
fulva by Raistrick and coworkers.3 However the structures of 1 and 4
were only established some 30 years later by X-ray analysis.4,5
Barton and coworkers subsequently reisolated 4 from Penicillium
purporogenum and began considering the biosynthesis of the
nonadrides.6 The cis relative stereochemistry of the ethyl and propyl
groups of byssochlamic acid was confirmed by X-ray analysis of the
bis-p-bromophenylhydrazide.5 The absolute configuration of 1 was
established by classical degradative methods,7 and subsequently
confirmed by enantiospecific synthesis of (+)-byssochlamic acid.8
All three metabolites, 1, 3 and 4, were hypothesised to be
biosynthesised via alternative dimerisationmodes of a C9/C10-maleic
acid precursor 5 and/or 6, and evidence for this was obtained by
feeding studies with radiolabelled 6.9 Many more nonadride
metabolites have since been reported, e.g. heveadride 7,10 an
isomer of 1, and others which are expected to be biosynthesised
through dimerisation of diﬀerently substituted maleic anhydride
units, including scytalidin 8,11 and castaneolide 9.12 More complex
examples include rubratoxin A 10, and its dihydro-analogue rubra-
toxin B 11,13 and phomoidrides A 12 and B 13.14 Cornexistin 14, is a
nonadride unique in having a single anhydride unit.15 Viburspiran
1516 and zopfiellin 16,17 feature 8-membered carbocyclic rings and
so have been classed as octadrides. Notably, all of the compounds
belonging to this family reported so far have been isolated from
fungi.
Pursuing a general interest in the biosynthesis of nonadrides and
other related fungal compounds, we re-analysed the secondary
metabolite profile of B. fulva to assess its nonadride-related meta-
bolites in greater detail. This has led to isolation and characterisation
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of a new analogue, dihydro-byssochlamic acid 2; two novel
metabolites agnestadride A 17 and agnestadride B 18, both
containing 7 membered rings which we have therefore termed
heptadrides; and as a natural product for the first time, the
proposed nonadride precursor, maleic anhydride 5 along with
its decarboxylated derivative 6.
B. fulva, was grown as described by Raistrick3 in static culture in
Czapek-Dox liquid medium with glucose as the sole carbon source
for between 7 and 30 days. The crude ethyl acetate extracts were
analysed by LCMS. Byssochlamic acid 1 (C18H20O6) was detectable
after 7 days of static fermentation (Fig. 1, 15.4 min) and large
amounts (450 mg L1) could be isolated after 4 weeks. Its identity
was confirmed as (+)-byssochlamic acid by comparison of 1D
1H and 13C NMR spectra, and optical rotation comparison with
literature values.8 Detailed analysis of 2D NMR spectra (COSY,
HSQC and HMBC) allowed all signals in the 1H and 13C NMR
spectra to be fully assigned for the first time (Table S1, ESI†).
The second-most abundant component of the extract eluted
at 11.3 min (Fig. 1). The new compound had a UV absorption
characteristic for nonadrides (lmax 211, 260 nm), ionised well in
the negative ESIMS mode and had the same fragmentation
pattern as byssochlamic acid 1 – the only difference being that
all of the peaks appeared at m/z values two units higher.
HRESIMS analysis confirmed the molecular formula to be
C18H22O6, corresponding to a reduced form of 1. Dihydrobysso-
chlamic acid 2 was purified by mass-directed preparative HPLC.
The NMR spectra (Table S1, ESI†) were compared with those of
byssochlamic acid 1. A new peak at 95.9 ppm in the 13C NMR
spectra correlated (HSQC) to H-10 at 5.71 ppm confirmed the
presence of a hemi-acetal in 2. Consistent with the loss of the
carbonyl, the resonances of C-11 and C-9 appeared at higher
chemical shifts (172.2 and 160.7 ppm respectively), and the C-8
resonance moved upfield to 130.6 ppm. Key HMBC signals
included correlations between 1-CH2 protons (2.42/2.32 ppm)
and C-8, C-9 and C-10; C-9, C-8 and C-11 but not C-10 correlated
also to H-7 (2.81 ppm), consistent with the lactol hydroxyl being
attached to C-10. Moreover, 6-CH2 (3.03/2.60 ppm) showed
correlations with C-8, C-4, C-5 and C-13 (130.1, 139.1, 139.9
and 168.5 ppm respectively) but not C-11 or C-9 (171.8 and
160.3 ppm). Interestingly, closer inspection of the 1H NMR
spectrum showed the presence of one major singlet at 5.71 ppm
consistent with the hemi-acetal adopting one major configu-
ration (68%) but three other singlet methine signals were
apparent at 5.80 (16%), 5.84 (5%), and 5.93 (11%) ppm respec-
tively. While one of these minor components is likely to be due
to the epimeric lactol, the other two signals may be due to
regioisomeric lactols. Other nonadride lactol analogues are
known, e.g. rubratoxin B 1113 and dihydro- and tetrahydroepi-
heveadrides (e.g. 7 R = H, OH, * = S) have been isolated from
Wicklowia aquatica, along with the corresponding lactones.18 In
phomoidride A 12, one of the anhydrides is found as a hemi-acetal
due to a transannular C–C bond, and in phomoidride B 13 as a full
acetal due to further linkage to a side chain hydroxyl.14
LCMS chromatograms of extracts from older cultures of B. fulva
(ca. 30 days) showed a new peak at 13.3 min with the same
molecular weight as byssochlamic acid 1 but a slightly diﬀerent
UV spectrum. It was isolated by HPLC (B1 mg L1 culture) and
HRESIMS confirmed it to have the same molecular formula
(C18H20O6) as byssochlamic acid. However,
1H NMR analysis
(Table S2, ESI†) showed the presence of a 1-butenyl side chain.
The HSQC spectrum revealed only nineteen hydrogens attached
to carbon, suggesting that the other belonged to a hydroxyl. The
presence of a further propyl substituent linked to an otherwise
uncoupled CH, and two mutually coupled methylenes were
obvious from the COSY spectrum (Fig. 2a). The characteristic
signals for one maleic anhydride were apparent at 143.3 (C-11),
165.3 (C-12), 164.8 (C-13) and 144.9 (C-14) ppm. The remaining 4
carbons resonances at 168.5 (C-6), 127.0 (C-5), 153.4 (C-8) and
104.0 (C-7) ppm were indicative of an a,b-unsaturated ester/
lactone and an acetal, consistent with the hydroxylactone moiety
indicted in bold in Fig. 2a. Further detailed analysis of the
HMBC data (Fig. 2b) was consistent with the seven-membered
carbocycle, which we name agnestadride A 17. The key correla-
tions were seen from the butenyl H-4 (6.08 ppm) to C-5, C-6 and
C-8, and from H-16 (3.54 ppm) to C-7, and 9-CH2 (3.01/2.66 ppm)
to C-5, C-7 and C-8 to firmly locate the hydroxylactone ring.
Similarly, correlations from 9-CH2 to C-10 (20.6 ppm) and C-11,
and 10-CH2 (3.05/2.52 ppm) to C-11, C-12 and C-13 locate the
maleic anhydride moiety.
A less polar new compound was detected (18.4 min in Fig. 1)
and was isolated (1 mg L1) using mass-directed preparative HPLC.
It had a mass of 314 (peak of m/z 313 [M  H] in the negative
ESIMS spectrum), corresponding to a dehydrated derivative of 17.
The formula was confirmed by HRESIMS analysis to be C18H18O5.
In contrast with other colourless metabolites isolated from B. fulva
compound 18 was bright yellow. The 1H NMR spectrum revealed
Fig. 1 HPLC (DAD) chromatogram of B. fulva extract.
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that 18 also contained a pendant 1-butenyl side chain. A total of 18
protons were observed in the 1H NMR spectrum (Table S2, ESI†).
There were three 13C NMR resonances (166.2, 164.6 and 163.1 ppm)
characteristic for anhydride/unsaturated lactone carbonyls, and 6
quaternary olefinic carbons. The C-7 acetal and C-15 methine
signals in 18 were absent, being replaced by two quaternary olefinic
carbons. This data is fully consistent with compound 18, named
agnestadride B, being a dehydrated form of agnestadride A. The
structure is supported by HMBC correlations, from H-4 to C-5 and
C-6, as well as from 17-CH2 to C-15. To our knowledge, no
heptadrides have been previously reported as natural products.
Baldwin and co-workers, investigating biomimetic dimerisation of
putative nonadride maleic anhydride monomers isolated a hepta-
dride structure 19 which was also reported as being an intense
yellow compound.19
Barton and coworkers suggested that maleic anhydride 6 is
the precursor of 1.6 Although indirect and direct evidence has
accumulated for this hypothesis,6,20,21 anhydride 6 has never
been observed as a component of B. fulva fermentations.
Subsequent feeding studies on the phomoidrides utilising
synthetic precursor analogues by Sulikowski and coworkers22
indicated that the monomeric nonadride precursor unit may be
a carboxylated species, e.g. 5 for byssochlamic acid. In an
attempt to find 5 or 6 in extracts of B. fulva, we searched
extracted ion chromatograms of fresh extracts and identified a
candidate peak at 7.7 min (Fig. 1). This metabolite formed ions
of m/z 209.5, 165.5 in the negative ESIMS, which matched
masses of ions expected for 5 ([M  H] and [M  H  CO2]
respectively) andm/z 211.5, 193.3 in the positive ESIMS ([M + H]+
and [M + H – H2O]
+ respectively). This compound was purified,
but identification by full NMR (Table S3, ESI†) and HRESIMS
analysis surprisingly showed it to be 6, the decarboxylated form
of 5. Reinjection of 6 into the LCMS showed that it had a
different retention time to 5, suggesting that it had decarboxy-
lated during purification and/or subsequent analysis. So to
confirm the structure and study its stability maleic anhydride
5 was synthesised as shown in Scheme 1 based on previous work
by Sulikowski.22 Commercially available mucobromic acid 20
was protected as silyl ether 21 in 79% yield. (E)-2-(But-1-en-1-
yl)benzo[d][1,3,2]dioxaborole 22 prepared via the hydroboration
of 1-butyne with catecholborane23 underwent Suzuki cross-
coupling with 21 to give bromide 23 regio-selectively (as proven
by HMBC). No bis-coupling was observed and the trans-geometry
of the alkene was confirmed by a 16 Hz coupling constant in the
1H NMR spectrum. Palladium-catalysed coupling of the bromide
23 with silyl enol ether 24 (prepared separately by treatment of
tert-butyl acetate with LDA and TBSCl)24 afforded ester 25 in
an excellent yield of 93%. Removal of the TBS group with
HF–pyridine was sluggish, giving yields of 26 typically between
30–46%. The resulting lactol 26 was then oxidised efficiently by
Dess–Martin periodinane to 27 and final ester hydrolysis with
TFA generated anhydride 5 in 66% yield.
The identity of naturally occurring 5 was confirmed by
comparing its LCMS characteristics with the data collected for
the synthetic product. The synthetic compound was observed to
undergo decomposition to 6 spontaneously and decomposition
was complete in under 48 h. The less polar peak at 20.6 min
(Fig. S2, ESI†) had a similar UV spectrum to 5, however it did not
ionize well (the ESI spectrum shows a m/z 165 with a m/z of 209
but only in very concentrated samples), which was consistent
with the loss of the ionisable carboxylate group. In addition the
chemical shifts of peaks present in the 1H NMR spectrum of the
impure naturally occurring 5 matched those of the synthetic
analogue (Table S3, ESI†). Interestingly anhydride 6, did not
show any signal by ELS (Evaporative Light Scattering) detection
and attempts to purify it by HPLC resulted in yields much lower
than anticipated. This was attributed to volatility of 5, and was
confirmed by HPLC of a sample that had been allowed to
evaporate at room temperature. On re-addition of solvent HPLC
analysis showed that ca. 96% of the compound had evaporated.
Byssochlamic acid 1 exists in equilibrium with its mono-
hydrated diacid forms which appear together at 9.8 min in the
LCMS chromatogram (1a/1b in Fig. 1), as indicated by the
characteristic [M + H2O  H] ion (m/z 349.2) in the negative
ESIMS spectrum. This peak appeared in chromatograms of
purified byssochlamic acid 1 and of a purified mixture of
1a/1b. When re-injected, this reforms an equilibrium mixture
with byssochlamic acid 1. 1H NMR spectra showed that the ring-
closed form 1 is preferred in organic solvent, while the ring-open
forms 1a/1b are also present in aqueous solvents. Similar behaviour
is observed for other maleic anhydride containing metabolites
including compounds 5 (see peaks at 7.35 and 4.88 min1 in
Fig. 1) and 6 (Fig. S3, ESI†) and dihydrobyssochlamic acid 2, and for
related maleic anhydrides isolated from P. variotii.25
Previous work26 had provided evidence for biosynthesis of
byssochlamic acid via dimerisation of maleic anhydride 6 the
decarboxylated form of 5. However, it would appear likely that 5
is the actual precursor, decarboxylation providing the exo-
methylene intermediate 28 necessary for cyclisation with a
second molecule of 5 as indicated in Scheme 2 (pathway a).
Tautomerisation of the first formed macrocycle leads to bysso-
chlamic acid 1. The heptadrides, agnestadrides A and B can be
accounted for by a diﬀerent mode of dimerisation of these
intermediates as indicated in Scheme 2 (pathway b). Formal
Michael addition of the anion derived by decarboxylation of 5
Scheme 1 Synthesis of anhydride 5. Reagents and conditions; (a) TBSCl
(1.2 eq.), imidazole (1.5 eq.), DMAP (0.05 eq.), DCM :DMF (6 : 1), r.t., 22 h,
79%; (b) (E)-2-(but-1-en-1-yl)benzo[d][1,3,2]dioxaborole 22 (1.2 eq.),
Pd(PPh3)2Cl2 (0.05 eq.), KOAc (2 eq.), PhMe, H2O, reflux, 16 h 79%; (c)
1-(tert-butyldimethylsilyloxy)-1-tert-butoxyethylene (2.04 eq.), Pd(PTol3)2Cl2
(0.05 eq.), KOAc (2 eq.), THF, reflux, 16 h, 93%; (d) HF–Py (70 :30) (3 eq.),
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now occurs on the other end of the diene system of 28. In the
in vitro studies19 leading to 19 strong base was required to trigger
dimerisation. Although presented in Scheme 2 as synchronous
processes, stepwise mechanisms are equally valid at this stage.
Interestingly diene 28 has been isolated as waquafranone B,
along with waquafranone A 29 and several epiheveadrides from
W. aquatica.18 Also, the exo-methylene compound 30 has been
isolated, as tubingenoic acid, from Aspergillus tubingensis,27
along with the hexyl analogue of 5, itself a metabolite of several
Aspergillus species.26,28,29
Our work with B. fulva has led to the isolation of 5 new maleic
anhydride-containing compounds in addition to byssochlamic acid.
These include dihydrobyssochlamic acid, but more significantly,
two novel 7-membered ring analogues which we have termed
heptadrides by analogy to nine-membered nonadrides and eight-
membered octadrides. Heptadrides have never been reported
previously as natural products.‡ In addition, the putative mono-
meric maleic anhydride intermediate previously proposed to
undergo macrocyclisation via dimerisation to give byssochlamic
acid and other nonadrides, has also been isolated for the first
time. A scheme for the biosynthesis of both the nonadrides and
heptadrides is proposed. Work is in progress to establish details
of the biosynthesis, as well as the identification of the biosynthetic
gene cluster.
To account for diversity among nonadride-like natural products,
we propose the generic namemaleidrides to denote biosynthetically
related compounds, with one (monomaleidrides) or two (bis-
maleidrides) maleic anhydride units anchored on a diversely
substituted ring. Production of the anhydride 5 by B. fulva,
along with hepta- and nonadrides, indicates that the diversity
among maleidrides very likely arises not only from diversely
substituted anhydride precursors, but also from alternative
dimerisation modes.
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